Biomarker and endpoint evidence

Make endpoint strategy visible before trial design locks.

Bayes Pharma Biomarker & Endpoint Studio evaluates biomarker rationale, assay validation, endpoint hierarchy, COA and DHT evidence, estimand fit, and regulatory precedent in one reviewable package.

Clinical Outcomes
Endpoint readiness

Endpoint package

--
Ready